Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT01977794

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01977794
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01977794. Randomized; no masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2015-03 (actual). Results posted on 2016-08-11.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension
Condition
Hypertension
Intervention (Drug)
Bisoprolol/Amlodipine (Bisoprolol failed group)
Intervention (Drug)
Bisoprolol/Amlodipine (Amlodipine failed group)
Lead sponsor
Merck KGaA, Darmstadt, Germany (class: industry)

Record details

Record id
cardio:ct-nct01977794
Content hash
c8dfe3972eac43d8642249e014032a85550e87db390bd3530d661b4eb511d2cb